Literature DB >> 2335599

Gadolinium enhanced MR imaging of vascular stents.

A H Matsumoto1, G P Teitelbaum, M J Carvlin, K H Barth, M A Savin, E P Strecker.   

Abstract

The feasibility of obtaining in-plane magnetic resonance (MR) vascular images in the presence of a vascular stent and the value of infusing an MR contrast agent during imaging was assessed. Coronal and sagittal MR imaging at 1.5 T was performed on six dogs with tantalum aortic stents using single-section gradient echo (GRE) imaging and MR angiography techniques before and during intravenous infusion of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA). In-plane gradient echo (GRE) imaging and MR angiography clearly showed flow within the stented vessel as increased signal, with a minimum amount of stent-related artifact. Infusion of Gd-DTPA significantly increased the signal of flowing blood and allowed for better delineation of the stented aortic lumina. Our results demonstrate that in-plane GRE imaging and MR angiography can potentially be used as noninvasive methods for evaluating vascular patency in the presence of MR-compatible endovascular devices. In addition, Gd-DTPA infusion during MR vascular imaging clearly enhances the definition of flowing blood in the lumina of stented vessels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335599     DOI: 10.1097/00004728-199005000-00006

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

1.  Magnetic resonance angiography of intravascular endoprostheses: investigation of three devices.

Authors:  J P Laissy; C Grand; C Matos; J Struyven; J F Berger; E Schouman-Claeys
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

2.  Utility of CT angiography and MR angiography for the follow-up of experimental aneurysms treated with stents or Guglielmi detachable coils.

Authors:  A M Masaryk; R Frayne; O Unal; A H Rappe; C M Strother
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.